Participate in Our Methamphetamine Trial

Iatalyst is conducting a clinical trial for methamphetamine users who want to discontinue use of the drug. The trial will be conducted in the cities listed below, and participants must live in, or nearby, one of the cities. If you wish to participate, please call the telephone number listed for your city.

Confidentiality: All information given by you to Catalyst will be held in strict confidence and will not be divulged except to contractors working with Catalyst Pharmaceutical Partners, Inc., for the purpose of conducting the clinical trial.

Compensation: Participants will be compensated.